India leads global innovation against one of the world’s deadliest health crises  

 

In a landmark innovation, Indian startup Shaktinetra Labs has launched Go Venom, the world’s first wearable device that instantly detects snake venom and administers life-saving antivenom automatically. The breakthrough offers new hope in tackling snakebite envenoming—one of the world’s most neglected health crises. According to the World Health Organization, up to 2.7 million people suffer snakebites each year, leading to 81,000–138,000 deaths. India accounts for nearly 58,000 annual fatalities, with remote tribal areas disproportionately affected due to delayed medical access.

 

“Go Venom is not just a device — it’s protection, hope, and survival for millions,” said Dr. Hraday Shah Judeo, inventor and founder of Shaktinetra Labs. Designed as a wearable “life shield,” Go Venom integrates multiple advanced technologies such as AI-powered biosensors detect venom within seconds of a bite. Smart microfluidics identify the venom type, automated injectors deliver the exact dose of antivenom and a regenerative gel minimizes tissue damage at the bite site. This self-contained system eliminates critical treatment delays, especially in rural regions lacking immediate medical support. It provides a potentially life-saving response within seconds—far quicker than traditional antivenom procedures. The invention is patented in India, co-owned by Shaktinetra Labs and the Ashit Anjana Heritage Foundation, a non-profit supporting healthcare innovation in underserved areas. Field trials are scheduled in Madhya Pradesh and Chhattisgarh, two high-risk states for snakebites, to evaluate Go Venom’s real-world effectiveness in tribal and rural settings. Recognized as a world-first innovation, Go Venom marks a major step forward in public health, placing India at the forefront of global snakebite response efforts.